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Are publicly available internet resources
enabling women to make informed fertility
preservation decisions before starting
cancer treatment: an environmental scan?
N. Mahmoodi1* , H. L. Bekker2, N. V. King2, J. Hughes3, G. L. Jones1
and on behalf of the Cancer, Fertility and Me research team
Abstract
Background: To identify publicly available internet resources and assess their likelihood to support women
making informed decisions about, and between, fertility preservation procedures before starting their cancer
treatment.
Methods: A survey of publically available internet resources utilising an environmental scan method. Inclusion
criteria were applied to hits from searches of three data sources (November 2015; repeated June 2017): Google (Chrome)
for patient resources; repositories for clinical guidelines and projects; distribution email lists to contact patient decision aid
experts. The Data Extraction Sheet applied to eligible resources elicited: resource characteristics; informed and shared
decision making components; engagement health services.
Results: Four thousand eight hundred fifty one records were identified; 24 patient resources and 0 clinical
guidelines met scan inclusion criteria. Most resources aimed to inform women with cancer about fertility
preservation procedures and infertility treatment options, but not decision making between options. There
was a lack of consistency about how health conditions, decision problems and treatment options were
described, and resources were difficult to understand.
Conclusions: Unless developed as part of a patient decision aid project, resources did not include
components to support proactively women’s fertility preservation decisions. Current guidelines help people
deliver information relevant to treatment options within a single disease pathway; we identified five additional
components for patient decision aid checklists to support more effectively people’s treatment decision making
across health pathways, linking current with future health problems.
Keywords: Patient decision aid, Shared decision making, Fertility preservation, Cancer treatment, eHealth, Environmental
scan
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Background
Providing accurate patient information is fundamental to
health services worldwide [1]. Since the 1940s, social sci-
ence research has informed guidance to enhance text
readability [2, 3] and health communications [4, 5]. Na-
tional and academic organisations provide best practice
guidance [6] for patient-focused intervention develop-
ment and evaluation [7, 8]. Research indicates patient re-
sources informed by these standards enhance health
literacy and patient benefits [9]. A challenge for service
delivery is to support patient-focused communications
about complex health problems; most guidance support
one-off decisions about a health problem in a single
pathway of care [10].
An iatrogenic consequence of cancer treatment is an in-
creased chance of impaired fertility; treatments can per-
manently damage the endocrine function and/or
reproductive systems needed to fall pregnant or carry a
baby to term [11]. Oncologists deliver care to minimise
these fertility-related effects using minimally gonadotoxic
therapies [12] and/or fertility sparing procedures (e.g.
trachelectomy, ovarian transpositioning, shielding) [13,
14]. For some women with impaired fertility after cancer
treatment, infertility treatments are offered [15]. Having
fertility preservation procedures before cancer treatment
may increase the likelihood of women having genetically
related children in the future, but can delay the start of
cancer treatment by a few weeks. Fertility services offer
the following preservation procedures: embryo cryopreser-
vation, oocyte cryopreservation, and ovarian tissue cryo-
preservation [16, 17].
Integrating relevant fertility preservation information
into cancer pathways is essential for women to make in-
formed decisions about whether to undergo fertility
preservation, and/or which procedures to choose [15,
18–25]. Receiving accurate and timely information is as-
sociated with reported better quality of life and reduced
decisional regret, post cancer treatment [22, 26–29].
However, women’s recall of discussions with health pro-
fessionals and support about infertility-related side-ef-
fects of cancer treatment is low [18, 30, 31]; findings
indicate variation in the timing, content, utility and
quantity of information about fertility preservation pro-
vided by cancer services [18, 31–33].
Increasingly the internet is accessed for health infor-
mation [34–38], and people find resources from stake-
holders independent of healthcare services (e.g. public,
professionals, charities, advocacy groups, product adver-
tisers, unregulated businesses) and in varied formats
(e.g. audio, video, text). These resources may provide ac-
curate information to support patient and carer health
literacy, or they may be misleading and difficult to
understand in the context of a person’s life, experience
and illness. It is unclear if and how systematically best
practice guidance are used to inform publically available
resources [39, 40]. This paper investigates what publi-
cally available resources are available to women about
fertility preservation choices before starting their cancer
treatment, and if they are sufficient to enable informed
decision making.
Methods
We carried out a survey of publically available patient
information and guideline resources to support women
diagnosed with cancer making fertility preservation
choices before treatment. We employed an environmen-
tal scan method used in applied health research for sys-
tematic analysis of Google search engine, targeted
website searches and contacting experts [41–44]. We
used this approach to search for resources freely avail-
able to any woman or health professional [34–38, 44];
internet searches can be more effective at identifying re-
ports [42] and informal material relevant to the topic
than academic or organisational databases [45, 46].
We followed the PRISMA reporting guidelines for best
practice in reporting systematic reviews of secondary
data synthesis [47]. These guidelines provide steps to en-
courage methodological rigour around the search, inclu-
sion criteria, extraction and synthesis of findings. The
target for this environmental scan is a resource (leaflet
or guideline) rather than an empirical study; the quality
of the target is judged against criteria known to boost
reasoning rather than those known to enhance meth-
odological rigour. A data extraction sheet was developed
to elicit systematically the key characteristics and con-
tent from each resource, which are described in tables
and synthesised within the results section.
Study context
This survey was carried out during the development phase
of the Cancer, Fertility and Me Patient Decision Aid
(CFM-PtDA) [48–50]. Other activities included (Nov
2015-Sept 2016): research governance and ethics; scoping
local and national patient information provided during
usual care by services to patients with cancer; mapping care
pathways between cancer and fertility services in Leeds and
Sheffield, UK; alpha testing [51] the CFM-PtDA prototype
with patients, oncology healthcare professionals and
other key stakeholders using qualitative methods. The
project received ethics approval by National Health
Service (NHS) Health Research Authority (HRA), East
Midlands Nottingham 1 Research Ethics Committee
in 2016, Ref: 16/EM/0122; HRA Ref:194751.
Information sources and search strategies
Health information is provided and used for different
purposes, such as to inform, reassure, persuade, ac-
quire skills and enhance reasoning [52–54]. We
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searched the internet for resources with minimum
standards for patient decision aids known to support
understanding of the health problem [4, 55, 56]; pro-
vide awareness of the advantages and disadvantages of
all relevant treatment options and their consequences
[52]; and support reasoned decision making [17, 52–
54]. These include components known to minimise
bias through providing balanced, neutral information
of all options and presentation of risk as natural fre-
quencies/ percentages [57–61]; a visual representation
of the decision problem [10, 62]; an evaluation of
these details in accordance with a person’s values [63–
66]; an explanation of people’s understanding of illness
and treatment [4, 55, 56, 67]; and allow for an in-
formed decision to be reached and implemented with
health professionals [59, 63, 68].
Three types of data source were searched between
November 11th – December 17th 2015, and repeated
in June 2017. Search terms, Uniform Resource Loca-
tor (URL) identifiers, and hits were managed using
Excel [42]:
1. Google (Chrome) was searched using 8 unique
search themes (cancer, breast cancer, leukemia,
lymphoma, gynaecological, surgery, radiotherapy,
chemotherapy), developed with an information
specialist (NVK). Within those themes there were 9
unique strategies which contained multiple
combinations of the following terms (UK and USA
spellings): cancer (all types); women (patient);
treatment (procedure); fertility preservation
(treatment); decision-making; information (booklet,
education, decision aid) (contact authors for further
information). All internet web-links, including spon-
sored links, on the first 5 pages of each search were
screened (n = 3600 websites) [42].
2. Open access repositories of patient decision aids,
clinical guidelines and active research were
searched using five search strategies developed with
an information specialist (NVK): Decision Aids
Library Inventory (DALI, Ottawa Health Research
Institute, Canada) (https://decisionaid.ohri.ca/
cochinvent.php); Trip clinical search engine https://
www.tripdatabase.com/); Clinical guidelines database-
NICE Evidence; (https://www.evidence.nhs.uk/);
Agency for Healthcare Research and Quality
National Guidelines Clearinghouse - AHRQ-NGC;
(https://www.guideline.gov/); UK and USA Clinical
trials databases (https://www.ukctg.nihr.ac.uk/;
https://clinicaltrials.gov/).
3. Experts (health professionals, patients and
researchers) in patient decision aid and shared
decision-making interventions and research were
contacted via the SHARED-L international email
distribution list. Experts were not asked to participate
in the study, but to simply email the study team with
information on any patient resources and guidelines
which met the study criteria. Four experts responded
by 31st January 2016, and all open-access resources
identified (n = 4) were included in the study.
Data selection
Patient resources with the following criteria were
included:
 Targeted women diagnosed with cancer and offered
fertility preservation options,
 Described fertility problems as a consequence of
cancer treatment,
 Described fertility preservation options and
consequences
 Contained an explicit statement to consider fertility
preservation options before cancer treatment.
Clinical guidelines with the following criteria were
included:
 Raised awareness of the link between cancer
treatment and fertility problems
 Contained explicit guidance on what fertility
preservation options to mention to women
diagnosed with cancer
 Explained the links between the fertility and cancer
management pathways
 Provided explicit guidance on how to support
women’s choices about fertility preservation options
in the context of their cancer care.
All resources were screened (NM) for inclusion in
the study; NM and HLB discussed decisions about re-
sources, included (n = 10), excluded (n = 10) and un-
certain (all). The search process and criteria were
discussed independently with GLJ, JH (November
2015).
Data extraction
A data extraction sheet (Additional file 1) was
developed (HLB, NM) with reference to patient deci-
sion aid research reviews and resource development
[2, 7, 8, 10, 35, 52–54, 69, 70], and cancer-related fer-
tility preservation decision aids [22, 26, 27, 29, 71, 72].
The presence or absence of minimum standards and
components know to support understanding of the
health condition, decision problem, treatment options
and their consequences, and reasoned decision making
were extracted systematically from each resource
meeting the scan’s inclusion criteria using the data ex-
traction sheet. The Data Extraction Sheet was piloted
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(NM, JH, GLJ), independently reviewed by the
CFM-PtDA project steering group (February 2016),
and applied systematically to eligible resources (NM,
JH) extracting the following:
 Characteristics: type of ‘e-resource’ (internet-
delivered, internet-adapted, internet-available) [35],
title, publisher, year of publication and of the
updated year, country, authors, funders, location
(URL), length, stated purpose resource.
 Quality indicators: Flesch readability formula [3] was
used to measure comprehensibility of leaflet (70–79
fairly easy; 60–69 standard; 50–59 fairly difficult;
30–50 difficult; 0–29 confusing), endorsed by third
party, developed systematically, listed evidence used
to inform content.
 Describes health problem: label and symptoms,
cause, time-line, consequences, cure and/or control,
and emotional responses to a) cancer, b) fertility /
infertility, and c) cancer-related infertility.
 Describes treatments: label /procedure, eligibility,
prognosis, side effects short term, side effects long
term for cancer treatment (chemo/ radio/ hormone
therapy, surgery), fertility preservation treatments
(egg/ embryo/ ovarian freezing, ovarian suppression/
shielding), and/or infertility treatments
(in vitro fertilisation, adoption/ fostering,
surrogacy).
Fig. 1 Study flow diagram - Resource and guideline identification, screening, and eligibility
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Table 1 Characteristics of guidelines meeting eligibility criteria (n = 0)
Guideline title Organisation (Country) Year of
publication
Year guideline
identified
Eligibility
criteria 1a
Eligibility
criteria 2a
Eligibility
criteria 3a
Eligibility
criteria 4a
Fertility preservation for AYAs diagnosed with cancer:
Guidance for health professionals
The clinical practice guideline portal
(Australia and New Zealand)
2011 2015 & 2017 x
South Australian Gynaecological Cancer Care Pathway
Optimising Outcomes for Women with Gynaecological
Cancer
The clinical practice guideline portal
(Australia and New Zealand)
2014 2015 & 2017 x
Clinical practice guidelines for the management and
support of younger women with breast cancer
National health and medical research
council (Australia and New Zealand)
2004 2015 & 2017 x
Clinical practice guidelines for the management of
women with epithelial ovarian cancer
National health and medical research
council (Australia and New Zealand)
2004 2015 & 2017 x
Clinical practice guidelines for the psychosocial care
of adults with cancer
National health and medical research
council (Australia and New Zealand)
2003 2015 & 2017 x
For the prevention, early Detection and management
of colorectal cancer
National health and medical research
council (Australia and New Zealand)
2005 2015 & 2017 x
The effects of cancer treatment on reproductive
functions.
Guidance on management
The Royal College of Physicians (UK) 2007 2015 & 2017 x
Fertility Sparing Treatments in Gynaecological Cancers Royal College of Obstetricians and
Gynaecologists (UK)
2013 2015 & 2017 x
Pregnancy and Breast Cancer Royal College of Obstetricians and
Gynaecologists (UK)
2011 2015 & 2017 x
Long term follow up of survivors of childhood cancer SIGN (UK) 2013 2015 & 2017 x x
Management of epithelial ovarian cancer SIGN (UK) 2013 2015 & 2017 x x
Management of cervical cancer SIGN (UK) 2008 2015 & 2017 x
Gynaecological cancer: guidance for nursing staff Royal College of Nursing (UK) 2005 2015 & 2017 x
Classical Hodgkin’s Lymphoma; 1st Line British Committee for Standards in
Haematology (UK)
2014 2015 & 2017 x x
For the diagnosis and Management of lymphoma National Health and Medical Research
Council (UK)
2005 2015 & 2017 x x
Fertility problems and assessment NICE (UK) 2014 2015 & 2017 x x
Fertility Pathway NICE (UK) 2014 2015 & 2017 x x x
Guidelines for the investigation and management of
nodular lymphocyte predominant Hodgkin lymphoma
British Committee for Standards
in Haematology (UK)
2015 2015 & 2017 x
Cancer, fertility and pregnancy ESMO (European) 2010 2015 & 2017 x
Cervical Cancer: ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow-up
ESMO (European) 2012 2015 & 2017 x
Non-epithelial ovarian cancer: ESMO Clinical
Practice Guidelines for diagnosis, treatment and
follow-up
ESMO (European) 2012 2015 & 2017 x
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Table 1 Characteristics of guidelines meeting eligibility criteria (n = 0) (Continued)
Guideline title Organisation (Country) Year of
publication
Year guideline
identified
Eligibility
criteria 1a
Eligibility
criteria 2a
Eligibility
criteria 3a
Eligibility
criteria 4a
Primary breast cancer: ESMO Clinical Practice
Guidelines for
diagnosis, treatment and follow-up
ESMO (European) 2015 2015 & 2017 x x
Preservation of Fertility in Paediatric and Adolescent
Patients With Cancer
American Academy of Paediatrics
(USA)
2009 2015 & 2017 x x
ACR Appropriateness Criteria pre-treatment planning
of invasive cancer of the cervix
American College of Radiology -
Medical Specialty Society (USA)
2011 2015 & 2017 x
American Society of Clinical Oncology
Recommendations
on Fertility Preservation in Cancer Patients
American Society of Clinical Oncology
(USA)
2006 2015 & 2017 x x x
Cancer of the uterine cervix Alberta health (USA) 2014 2015 & 2017 x
Epithelial ovarian, fallopian tube, and primary
peritoneal
cancer
Alberta health (USA) 2012 2015 & 2017 x
Ovarian germ cell tumours Alberta health (USA) 2013 2015 & 2017 x
Lymphoma Alberta health (USA) 2014 2015 & 2017 x
Management of gynaecologic issues in women
with breast cancer
American College of Obstetricians
and Gynecologists (USA)
2013 2015 & 2017 x
Breast Cancer: Management and Follow-up Clinical Practice Guidelines and Protocols
in British Columbia (Canada)
2013 2015 & 2017 x x
aEligibility criteria 1: Raised awareness of the link between cancer treatment and fertility problems
2: Contained explicit guidance on what fertility preservation options to mention to women diagnosed with cancer
3: Explained the links between the fertility and cancer management pathways
4: Provided explicit guidance on how to support women’s choices about fertility preservation options in the context of their cancer care
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Table 2 Characteristics of resources meeting eligibility criteria (n = 24)
Study
No.
Source Resource Title Organisation (Country) Resource Typea Target
Group
Cancer Type Year
resource
identified
Year of
publication
(updated)
No.
pages
Readability
Flesch
Score [2]
1 Google Cancer Treatment Fertility-
Information for Women
Macmillan Cancer Support (UK) Internet- available Adult Any cancer 2015 &
2017
2013
(2016)
50 55
2 Google Fertility care for Women
Diagnosed with Cancer
Central Manchester University
Hospital- St Mary’s Hospital (UK)
Internet- available Adult Any cancer 2015 &
2017
2013 16 48
3 Google Save My Fertility: Fertility
Preservation for Women
Diagnosed with Cancer
The Onco-fertility Consortium
(USA)
Internet- delivered, Internet-
available & Mobile App
Adult &
TYA
Any cancer 2015
&2017
2011 5 35
4 Google Fertility and Breast Cancer
Treatments
Breast Cancer Care (UK) Internet- available Adult Breast 2015
&2017
2014
(2017)
22 52
5 Google Fertility and Women with
Cancer
American Cancer Society
(USA)
Internet- delivered & Internet-
available
Adult &
TYA
Any cancer 2016 &
2017
2013 25 48
6 Google Fertility and Pregnancy
Issues During and After
Breast Cancer
Breast Cancer.org (USA) Internet- delivered Adult Breast 2015 &
2017
2015 21 57
7 Google Fertility and Cancer: A Guild
for People With Cancer, Their
Friends and Families
Cancer Council (Australia) Internet- available Adult &
TYA
Any cancer 2015 &
2017
2014
(2016)
86 45
8 Google Breast Cancer and Fertility Europe Donna Ireland (Ireland) Internet- available Adult Breast 2015 &
2017
2008 16 48
9 Google Oncofertility Flinders Fertility (Australia) Internet- available Adult Any cancer 2015 &
2017
2013 14 32
10 Google Can I Still Have Children? Melbourne IVF and Royal
Women’s Hospital (Australia)
Internet- available Adult Any cancer 2015 &
2107
2013 20 41
11 Google Fertility Concerns and
Preservation for Women
Cancer.net (USA) Internet- delivered Adult Any cancer 2015 &
2017
2014 5 27
12 Google Fertility Preservation:
Options for Women Who
Are Starting Cancer Treatment
Memorial Sloan- Kettering
Cancer Centre (USA)
Internet- available Adult Any cancer 2015 &
2017
2015 14 47
13 Google Fertility New Zealand Breast Cancer
Foundation (New Zealand)
Internet- delivered Adult Breast 2015 &
2017
2013 2 47
14 Google Caring for Adolescents and
Young Adults
NCCN guidelines for Patients
(USA)
Internet- available & Internet-
delivered
TYA &
Parents
Any cancer 2015 &
2017
2013 118 53
15 Google Fertility Preservation in Cervical
Cancer
North London Gynaecological
Cancer Network (UK)
Internet- available Adult Gynaecological
cancers
2015 &
2017
2015 10 42
16 Google Fertility and Cancer New life (UK) Internet- delivered Adult Any cancer 2015 &
2017
2015 7 55
17 Google Fertility Preservation for Women
with Cancer: FAQs
Walgreens (USA) Internet- available Adult Any cancer 2015 &
2017
2011 8 41
18 Google Fertility Options to Consider Fertile Hope & Cleveland Clinic Internet- available Adult Any cancer 2015 & 2005 12 49
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Table 2 Characteristics of resources meeting eligibility criteria (n = 24) (Continued)
Study
No.
Source Resource Title Organisation (Country) Resource Typea Target
Group
Cancer Type Year
resource
identified
Year of
publication
(updated)
No.
pages
Readability
Flesch
Score [2]
Before Treatment Begins and
Parenthood
Options After Cancer
(USA) 2017
19 Google Fertility Preservation University of Iowa Hospitals
and Clinics (USA)
Internet- available Adult Any cancer 2015 &
2017
2013 21 48
20 Google Future Fertility: Preserving Fertility
in Women
with Cancer
University of New South Wales,
Onco-fertility Consortium,
Prince of Wales Hospital
(Australia)
Internet- delivered & Internet-
available
Adult Any cancer 2015 &
2017
2015 52 58
21 Google Fertility Facts Lymphoma and Leukaemia
Society (USA)
Internet- available TYA Lymphoma
and Leukaemia
2015 &
2017
2015 7 41
22 DALI
database
Breast cancer and having
children
Leiden University Medical
Centre/ Pink Ribbon (Dutch)
Internet- adapted Adult Breast 2015 &
2017
2012 31 47
23 Expert
contacts
Learning About Cancer and
Fertility: A Guide for Parents
of Young Girls
North western University/
Onco-fertility Consortium
(USA)
Internet- available Parents Any cancer 2015 &
2017
2011 24 55
24 Expert
contacts
Fertility-related choices: A decision aid
for younger women with breast cancer
University of Melbourne/
Breast Cancer Network/
Prince of Wales Hospital
(Australia)
Internet- available Adult Breast 2015 &
2017
2013
(2016)
57 78
aResource type [35]: Internet-delivered include all PtDAs for which some or all parts are delivered using the Internet
Internet- available include PtDAs that were initially developed and tested in other formats (e.g., paper, audio, or video), then made available on the Internet for individuals to download, print, and complete
Internet- adapted include PtDAs created in other formats that were purposefully adapted to allow individuals to use them directly on the Internet. Examples include adapting paper worksheets into interactive
questionnaires, and adapting text and video components of PtDA DVDs into websites
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 Signposts illness-wellness trajectory: care pathways;
quality of life.
 Decision architecture to boost/ bias thinking:
trade-offs between options; decision picture;
decision guidance; other’s values/ stories; risk
presentation; treatment preference.
 Health service engagement: prompts to prepare for
consultations, friends and families; diagrams/
guidance to prepare for procedures; signposting to
other information.
Data synthesis and analysis
Two quality-assessment grids were applied to synthesise
evidence across resources: The IPDAS grid - 12 compo-
nents identified as minimum criteria for a patient deci-
sion aid resources [8, 9, 44, 69, 70]; Informed Decision-
Making (IDM) grid - 10 components known to boost in-
formed and shared decision-making, and minimise rea-
soning bias [52–54]. Each item scored either 0 (present)
or 1 (not present); Summed total scores were IPDAS
grid (0–12), and IDM grid (0–10).
The findings are presented using narratives and fre-
quency statements to address whether or not women
and health professionals have access to publicly available
online resources that support fertility preservation deci-
sions before cancer treatment. SPSS statistical software
was used to manage the data elicited from the resources.
Descriptive data were used to assimilate findings across
resources, and show the number of occurrences for each
component on the data extraction sheet.
Results
Shown in Fig. 1, the search yielded 147 unique records
eligible for assessment (n = 116 e-resources and n = 31
guidelines). Following screening, none of the 31 guide-
lines met the scan’s inclusion criteria (Table 1); although
all guidelines make links between the consequences of
cancer treatment and fertility problems, only 7 highlight
guidance around availability of fertility preservation
treatments, only 5 made links between cancer and fertil-
ity management pathways for women, and none pro-
vided guidance for professionals on how to support
women’s decision making about fertility preservation op-
tions in the context of their cancer care.
Following screening, 24 patient resources met the
scan’s inclusion criteria (Table 2). Most resources were
suitable for women with any cancer type (n = 16), and
most were designed for adults (n = 16). Resources were
published between 2005 and 2017, all but one (SN22) in
English, one (SN24) was judged as fairly easy to read,
and one (SN22) was internet-adapted by using an inter-
active web-based platform (Table 2). All resources stated
their publisher, thirteen described the development
team, ten included references of the evidence-base
informing the resource content, four stated they were
endorsed by a third party, three published peer-reviewed
papers demonstrating the resource’s development and/or
evaluation, and two were located on the publicly avail-
able DALI (Table 3).
Meeting minimum standards for patient decision aid
resources
All resources eligible for the study provided information
about the health conditions and treatment options
(Table 4). The stated aim for 18 resources was to provide
information about cancer, fertility and infertility options;
7 stated their purpose was to support making a decision
between treatment options (SN8, SN10, SN11, SN12,
SN18, SN22, SN24). Of these, 3 focused on decisions be-
tween having cancer treatment with or without fertility
preservation (SN2, SN3, SN23), 3 between fertility pres-
ervation options (SN22, SN23, SN24), and 2 between in-
fertility treatments to have a family (SN22, SN24).
All 24 resources encouraged women to talk to their
cancer care and/or fertility specialist teams, and/or speak
with friends and family; 15 (SN3, SN6, SN7, SN8, SN11,
SN13, SN14, SN16, SN18, SN19, SN20, SN21, SN22,
SN23, SN24) provided questions to support shared deci-
sion making in consultations with health professionals.
No resources included all the components identified as
part of the minimum standards for a patient decision aid
[9]; the median score was 4 out of 12 points (range 2–8)
(Table 4).
Inclusion of components boosting or biasing informed
decision-making
There were variations in how cancer and fertility problems
were described across resources (Table 5), with gaps in de-
tails to help women’s understanding of the causal links be-
tween having cancer treatment and an increased
likelihood of having fertility problems in the future. Most
resources (n = 21) described fertility-related options be-
fore, during and after cancer. Four (SN14, SN22, SN23,
SN24) resources used flow diagrams to illustrate links be-
tween choices and service delivery pathways. Seven pro-
vided diagrams and pictures to explain procedures (e.g.
In-vitro fertilisation) (SN1, SN2, SN7, SN10, SN12, SN23,
SN24) and six illustrated body systems (e.g. reproductive
system) (SN1, SN7, SN10, SN11, SN12, SN23).
There was variation in the amount of information
given about treatment options for the short and long-
term consequences of cancer-related fertility (Table 6).
Ten resources included prompts encouraging women to
describe what was important to them about infertility-
treatment options (Table 7); one provided quality of life
statements to help women’s reasoning (SN7). Three re-
sources used an option-by-attribute table format to sum-
marise details (SN5, SN23, SN24), and two used
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trade-offs based on their values (SN22, SN24). The
health professionals’ opinion was provided in two re-
sources (SN1, SN6), and other women’s stories about
their experiences in four resources (SN1, SN7, SN14,
SN24).
Resources provided risk statements about: cancer treat-
ment side effects; cancer treatment impact on fertility; fertil-
ity preservation side effects to women and/or the baby; risk
of cancer reoccurrence; success of fertility preservation treat-
ments. Usually risk was presented as a verbal descriptor (e.g.
low, high, likely) (n= 24), nine used percentages (SN2, SN6,
SN8, SN15, SN16, SN18, SN19, SN22, SN24) and/or figures
with the same common denominator across the resource
(e.g. 1 in 100) (n= 1) (SN1), and three used graphs, bar
charts and iconography figures (SN12, SN22, SN24). None
provided information about the levels of uncertainty around
event or outcome probabilities. Few provided balanced de-
tails about the risks and benefits of fertility preservation op-
tions; three (13%) described positive features (benefits)
(SN17, SN19, SN24), and eight (33%) negative features
(harms) (SN2, SN4, SN5, SN12, SN17, SN19, SN22, SN24).
No resources included all the components identified for
boosting informed and shared decision making [52–54]; the
median score was 3 out of 10 points (range 2–8) (Table 7).
Discussion
The search strategies identified 4851 cancer and fertility
resources (Fig. 1). It took six weeks of systematic analysis
to identify those integrating fertility preservation options
within the cancer care pathway. Those meeting the scan’s
Table 3 Assessment of Resource Development Quality (n = 24)
Development Process Item Study Number of Resource Number of resources
including component
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Publishers
Service providers x x x x x x x 7
Charity organisation x x x x x x x x x 9
Mixed (service, charity,
academic)
x x x x x x 6
Pharmaceutical companies x x 2
Stakeholders
Communication or decision
scientist
x x 2
Charity representative x x x x x 5
Patient or advocacy groups x x x x x 5
Fertility professional x x x x x x x x 8
Cancer professionals x x x x x x x x x x 10
Primary healthcare professionals x x x x x x x 7
Pharmaceutical organisation x 1
Applied researchers x x x x 4
Health care professional
organisation
x x x x x x 6
Endorsement Referenced In Resource
Information standard x x 2
Professional body 0
Patient advocacy x x 2
IPDAS endorsement 0
Evidence-Base Referenced In Resource
Evidence-based publication in
resource
x x x x x x x x x x 10
Quality Publication About Resource
Publication of development/
evaluation
x x x 3
Located on recognised
repository (DALI)
x x x 3
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criteria were predominantly information resources for
women with cancer, raising awareness of fertility preserva-
tion and informing about infertility treatment options. De-
tails describing the two related health problems, cancer
and fertility problems, varied across resources. Three re-
sources met the minimum criteria for recognition a pa-
tient decision aid [7, 9]; all three were developed and
evaluated within research projects. Six used components
and structures known to help people think actively about
treatment options in accordance with their own values
(Tables 4 and 7). No clinical guidelines enabled cancer
professionals to prepare women for fertility preservation
decisions and/or service referral; guidance was to read
quality standards and/or clinical guidelines for treating
fertility problems [15, 19]. As health professionals are not
provided with guidance on enabling fertility preservation
decisions in the context of cancer rather than infertility
treatment, and relevant patient information is not easily
accessible, these results explain in part why women with
cancer feel simultaneously unsupported and overwhelmed
by information at this time-pressured point in their treat-
ment management [18, 22, 28, 29, 31, 73].
Table 4 Resource assessed for inclusion of components within Patient Decision Aid Resources (IPDAS) (n = 24) [8, 69, 70]
IPDAS Checklist Item Study Number of Resources
Including Component
Number of resources
including component
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
1. Describes health condition for
index decision
x x x x x x x x x x x x x x x x x x x x x x x x 24
2. Explicitly describes the index
decision being considered
x x x x x x 6
3. Describes the options x x x x x x x x x x x x x x x x x x x x x x x x 24
4. Describes positive features all
options
x x x 3
5. Describes negative features all
options
x x x x x x x x 8
6. Describes what it is like to
experience the psychosocial
consequences of options
0
7. Shows negative and positive
features of all options in equal
detail (text amount, equal stats/
consequences)
x x 2
8 Cites evidence used or links to
document
x x x x x x x x x x 10
9. Provides a publication date
resource
x x x x x x x x x x x x x x 14
10. Provides information about an
update policy
x x x x x x x x x x 10
11. Provides information about
uncertainty level around event
/outcome probabilities
0
12. Provides information about the
funding source used for
development
x x x x x x x 7
Total score IPDAS (out of 12) 5 6 5 6 6 3 4 4 3 4 3 4 2 6 3 2 7 4 4 3 2 8 5 8
Table 5 Details of health conditions described, by illness-schemata category (n = 24) [56]
Cancer
(16/24)
Fertility
(14/24)
Infertility
(13/24)
Cancer-Related
Infertility (24/24)
Label/symptom 3 (13%) 7 (29%) 4 (17%) 9 (38%)
Timeline 1 (4%) 6 (25%) 5 (21%) 21 (88%)
Cause 2 (8%) 11 (46%) 2 (8%) 14 (58%)
Consequence 15 (63%) 3 (13%) 5 (21%) 19 (79%)
Cure/control 5 (21%) 1 (4%) 7 (29%) 17 (71%)
Mahmoodi et al. BMC Medical Informatics and Decision Making          (2018) 18:104 Page 11 of 16
Using the environmental scan method provided a
rigorous way to identify fertility preservation resources
[42, 74]. Our data extraction sheet enabled us to critique
resources systematically against established quality stan-
dards for written information [2, 4, 8, 69, 70]. However,
there are limitations to using these type of web-based
methods that may impact on our findings. Retrieving all
resources is difficult due to the volume of material avail-
able on the internet [42, 46] and the lack of archiving
and differing terminology used by developers [42]. Web-
site content and location can change over time [75] and
Google search algorithms and personalisation features
Table 6 Treatments described across resources for cancer and fertility problems (n = 24)
Cancer Treatment Fertility Preservation Options
Chemotherapy 23 (96%) Egg freezing 22 (92%)
Radiotherapy 23 (96%) Embryo freezing 23 (96%)
Surgery 17 (71%) Ovarian tissue freezing 21 (88%)
Hormone therapy 8 (33%) Ovarian suppression 13 (54%)
Targeted therapy 4 (17%)
Ovarian suppression as part of cancer treatment 5 (21%)
Family Planning During Cancer Infertility Treatment/ Family
Planning After Cancer
Contraception 11 (46%) Natural 17 (71%)
Assisted conception 17 (71%)
Surrogacy 16 (67%)
Adoption / fostering 15 (63%)
Contraception 12 (50%)
Table 7 Resource assessed for components boosting or biasing informed and shared decision making (I/SDM) (n = 24) [52–54]
I/SDM Component Study Number of Resources including Component Number of resources
including component
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
1. Provides accurate information
about all options (IDM)
x x x x x x x x x x x x x x x x x x x 19
2. Helps people think about what
matters to them about the options
(IDM)
x x x x x x x x x x 10
3. Supports reasoning about all
options without bias (IDM)
x x x x x 5
4. Presents figures in ways to
support understanding (IDM)
x x 2
5. Encourages people to trade-off
their evaluations to make a choice
(IDM)
x x 2
6. Encourages people to share
reasoning with their health
professionals (SDM)
x x x x x x x x x x x x x x x x x x x 19
7. Focuses thinking about the
decision in the context of their
lifestyle (IDM)
x 1
8. Places the decision in the
context of a changing illness-
health state (IDM)
x x x x x x x x x x x x x x x x x x x x x 21
9 Enables decision to be
implemented within care pathway
(SDM)
x 1
10. Encourages comparisons
between different decisions (IDM)
x x x x 4
Total Judgement score (out of 10) 2 2 3 4 3 4 5 2 3 3 2 5 2 3 2 3 3 3 3 3 3 7 5 8
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linked to geographical location and previous search his-
tory all influence the results retrieved [42, 46, 75]. Ideally
more than one search engine should be searched as they
use different algorithms affecting relevance rankings and
subsequent resource retrieval [76], patients also use dif-
ferent browsers or search engines. Best practice guidance
for internet searches is developing [41], conducting an
environmental scan using three complementary search
strategies and repeating the Google search a year later
from a different organisation should help to minimise
the risk of missing key resources and address some of
the bias in our search methods [42, 44, 74].
From our synthesis and critical evaluation of re-
sources, we identified components likely to support pro-
actively women’s health literacy and reasoning in
decisions which cross medical specialty. First, explicit la-
belling linking the current illness with the future health
problem (e.g. cancer-related fertility problem) helps es-
tablish causality between the current treatment and its
iatrogenic consequence. Second, including details
describing the future health across all illness representa-
tion dimensions (label/ symptoms, cause, time-line, con-
sequences, cure/control) to enable women to have a
coherent understanding of the short and long-term
cancer-related fertility problems arising. Third, describ-
ing the fertility preservation decisions, and presenting all
options with equivalent and balanced information, to en-
able stakeholders to focus on details relevant for women
having cancer treatment. Fourth, signposting to other
fertility-related choices within the cancer treatment tra-
jectory raises awareness for women’s involvement at the
right time in the cancer pathway [48] (Fig. 2). Fifth, de-
scribe risk figures and elicit preferences about the fertil-
ity preservation options to focus the discussion on
information relevant to the context of starting, and
minimising the consequences of, cancer treatment. Sev-
eral resources encouraged women to rate their prefer-
ences for in-vitro fertilisation, surrogacy, adoption and
fostering, i.e. options for women receiving treatment for
fertility problems. People’s’ preferences are labile [77],
Cancer diagnosis and treatment planning
Fertility preservation decisions before cancer treatment
Not to preserve fertility Freezing Ovarian supression
Egg Embryo Tissue
Cancer treatment and care
Contraception during cancer treatment
Barriers 
(condom, 
diaphragms)
IUD
(coil, intrauterine 
device)
Hormone 
(pill, implant, 
injection)
Abstinence 
(not sexually 
active)
Cancer follow-up and monitoring
Family planning decisions after cancer treatment
Contraception
Having children 
with pregnancy
Having children 
without pregnancy
Using own 
frozen eggs/ 
embryo/tissue
Natural
Donor 
eggs or 
embryo
Surrogacy Adoption Fostering
Fig. 2 Decision map integrating fertility options within cancer-care pathway [48]
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and eliciting women’s values towards children,
life-partners, and infertility treatments before they have
a fertility problem, and whilst they are ill with cancer,
may have limited value to making a decision about fertil-
ity preservation when being treated for cancer.
Conclusions
Achieving patient-centred integrated cancer care requires
effective communication between patients and profes-
sionals [23, 68, 78]. Current clinical guidelines, patient re-
sources, and patient decision aid frameworks provide little
guidance enabling services to provide standardised infor-
mation supporting cross-specialty decisions about health
options. In consequence, there is variation in what infor-
mation women receive within cancer services about fertil-
ity preservation, and can access from web-sites. We
suggest components based on our study’s synthesis and
critical evaluation can be used in resource development
guidance to inform the content and structure of patient
resources, clinical guidelines and shared decision making
training to support more effectively women making fertil-
ity preservation decisions before starting their cancer
treatment. Providing an infrastructure to ensure adoption
and maintenance of rigorously developed and evaluated
patient decision aids in relevant repositories is likely to in-
crease women’ access to appropriate resources [79]. As is
raising awareness and skills of utilising social science evi-
dence when developing and designing patient information
and professional guidelines to support people making
healthcare decisions.
Additional file
Additional file 1: Environmental scan – open access patient decision
aids cancer treatment_fertility preservation -- Data extraction form.
(DOCX 31 kb)
Abbreviations
AHRQ-NGC: Agency for Healthcare Research and Quality National Guidelines
Clearinghouse; CFM-PtDA: Cancer Fertility and Me Patient Decision Aid;
DALI: Decision Aids Library Inventory; HRA: Health Research Authority;
IDM: Informed Decision-Making; IPDAS: International Patient Decision Aid
Standards; NHS: National Health Service; NICE: National Institute of Health
and Care Excellence; SN: Study Number of Resource; URL: Uniform Resource
Location
Acknowledgements
We would like to thank and acknowledge the following members of the
Cancer, Fertility and Me research team for all the time, expertise and
comments they gave in the drafting of this manuscript for publication, and
for which we are extremely grateful.
The Cancer, Fertility and Me research team include:
Galina Velikova, Leeds Teaching Hospital NHS Trust; Diana Greenfield,
Sheffield Teaching Hospitals NHS Foundation Trust; Robert Phillips, Leeds
Teaching Hospital NHS Trust; Sheila Lane, Oxford University Hospitals NHS
Foundation Trust; Greta Brauten-Smith, Breast Cancer Care; Jacqui Gath,
Independent Cancer Patients’ Voices; John Snowden, Sheffield Teaching
Hospitals NHS Foundation Trust; Daniel Yeomanson, Sheffield’s Children NHS
Foundation Trust; Ellissa Baskind, Leeds Teaching Hospital NHS Trust; Tonia
Campbell, Patient Advocacy; Frances Darby, Leeds Beckett University;
Katharina Vogt, Leeds Beckett University; Jonathan Skull, Sheffield Teaching
Hospitals NHS Foundation Trust; Daniel Stark, Leeds Teaching Hospital NHS
Trust.
Funding
Study funded by Yorkshire Cancer Research (project award S391; 2015–2018).
The funding agreement ensured the authors’ independence in designing
this study, interpreting the data, writing, and publishing the report. The
views presented in this report are not necessarily representative of the
funder’s views and belong solely to the authors.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
Study idea: GLJ, HLB. All authors (GLJ, HLB, JH, NVK NM) made substantial
contributions to the study design, data acquisition and interpretation. All
authors (GLJ, HLB, JH, NVK NM) have been involved in drafting the
manuscript critically for important intellectual content. Post-review manu-
script revisions: HLB, NK, NM. All authors (GLJ, HLB, JH, NVK NM) have given
final approval of the version to be published and agreed to be accountable
for all aspects of the work.
Ethics approval and consent to participate
Ethics approval granted by National Health Service (NHS) Health Research
Authority (HRA), East Midlands Nottingham 1 Research Ethics Committee for
the project in 2016, Reference: 16/EM/0122; HRA Reference: 194751. Ethics
statements are not required for the environmental scan as data extracted
from publicly available written documents.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Psychology, School of Social Sciences, Leeds Beckett
University, Leeds LS1 3HE, UK. 2Institute of Health Sciences - School of
Medicine, University of Leeds, Leeds, UK. 3School of Health & Related
Research, University of Sheffield, Sheffield, UK.
Received: 1 June 2018 Accepted: 26 October 2018
References
1. World Health Organization. The mandate for health literacy 2016. Available
from: http://www.who.int/healthpromotion/conferences/9gchp/health-
literacy/en. Accessed 17 May 2018.
2. Coulter A, Entwistle V, Gilbert D. Informing patients : an assessment of the
quality of patient information materials. London: King’s Fund; 1998.
3. Scott B. Readability formulas 2018. Available from: http://www.
readabilityformulas.com. Accessed 17 May 2018.
4. Ley P. Communicating with patients: improving communication, satisfaction
and compliance. New York: Croom Helm; 1988.
5. Nutbeam D. Health literacy as a public health goal: a challenge for
contemporary health education and communication strategies into the 21st
century. Health Promot Int. 2000;15(3):259–67.
6. Medicines and Healthcare products Regulatory Agency. Best Practice
Guidance on Patient Information Leaflets 2014. Available from: https://www.
gov.uk/government/uploads/system/uploads/attachment_data/file/328405/
Best_practice_guidance_on_patient_information_leaflets.pdf. Accessed 17
May 2018.
7. Sepucha KR, Abhyankar P, Hoffman AS, Bekker HL, LeBlanc A, Levin
CA, et al. Standards for UNiversal reporting of patient decision aid
Mahmoodi et al. BMC Medical Informatics and Decision Making          (2018) 18:104 Page 14 of 16
evaluation studies: the development of SUNDAE checklist. BMJ Qual
Saf. 2018;27(5):380–8.
8. The International Patient Decision Aid Standards (IPDAS) Collaboration. Criteria
for Judging the Quality of Patient Decision Aids Checklist 2005. Available from:
http://ipdas.ohri.ca/ipdas_checklist.pdf. Accessed 27 Mar 2018.
9. Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision
aids for people facing health treatment or screening decisions. Cochrane
Database Syst Rev. 2017;4:CD001431.
10. Winterbottom AE, Gavaruzzi T, Mooney A, Wilkie M, Davies SJ, Crane D, et
al. Patient acceptability of the Yorkshire Dialysis Decision Aid (YoDDA)
booklet: a prospective non-randomized comparison study across 6
Predialysis services. Perit Dial Int. 2016;36(4):374–81.
11. Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of
chemotherapy and radiation on female reproduction. Clin Obstet Gynecol.
2010;53(4):727–39.
12. Mauz-Korholz C, Hasenclever D, Holzendorf V, Bernstadt M, Jurgens H,
Burdach S, et al. Feasibility of VECOPA, a dose-intensive chemotherapy
regimen for children and adolescents with intermediate and advanced
stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial.
Leuk Lymphoma. 2015;56(5):1308–14.
13. Arian SE, Goodman L, Flyckt RL, Falcone T. Ovarian transposition: a surgical
option for fertility preservation. Fertil Steril. 2017;107(4):e15.
14. Sato S, Itamochi H, Sugiyama T. Fertility-sparing surgery for uterine cervical
cancer. Future Oncol. 2016;12(20):2345–55.
15. National Institute for Health and Care Excellence. Fertility problems:
assessment and treatment: Clinical guideline [CG156]: NICE; 2013. Available
from: https://www.nice.org.uk/guidance/cg156. Accessed 27 Mar 2018.
16. Peccatori FA, Azim HA Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, et al.
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi160–70.
17. Waimey KE, Smith BM, Confino R, Jeruss JS, Pavone ME. Understanding
fertility in young female Cancer patients. J Women’s Health (Larchmt). 2015;
24(10):812–8.
18. Jones G, Hughes J, Mahmoodi N, Smith E, Skull J, Ledger W. What factors
hinder the decision-making process for women with cancer and
contemplating fertility preservation treatment? Hum Reprod Update. 2017;
23(4):433–57.
19. Lee R, Armstrong A. Chapter 17: Fertility issues in cancer treatment. In:
Velikova A, Followfield L, Younger J, Board RE, Selby P, editors. Problem
solving in patient-centred and integrated cancer care. Oxfordshire: EBN
Health; 2018. p. 87–91.
20. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al.
American Society of Clinical Oncology recommendations on fertility
preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–31.
21. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al.
Fertility preservation for patients with cancer: American Society of Clinical
Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10.
22. Peate M, Meiser B, Cheah BC, Saunders C, Butow P, Thewes B, et al. Making
hard choices easier: a prospective, multicentre study to assess the efficacy
of a fertility-related decision aid in young women with early-stage breast
cancer. Br J Cancer. 2012;106(6):1053–61.
23. Woodard TL, Hoffman AS, Covarrubias LA, Holman D, Schover L, Bradford A, et
al. The pathways fertility preservation decision aid website for women with
cancer: development and field testing. J Cancer Surviv. 2018;12(1):101–14.
24. Woodruff TK. The Oncofertility consortium--addressing fertility in young
people with cancer. Nat Rev Clin Oncol. 2010;7(8):466–75.
25. Quinn GP, Vadaparampil ST, Malo T, Reinecke J, Bower B, Albrecht T, et al.
Oncologists’ use of patient educational materials about cancer and fertility
preservation. Psychooncology. 2012;21(11):1244–9.
26. Ehrbar V, Urech C, Rochlitz C, Dallenbach RZ, Moffat R, Stiller R, et al. Fertility
preservation in young female Cancer patients: development and pilot testing
of an online decision aid. J Adolesc Young Adult Oncol. 2018;7(1):30–6.
27. Garvelink MM, ter Kuile MM, Fischer MJ, Louwe LA, Hilders CG, Kroep JR, et
al. Development of a decision aid about fertility preservation for women
with breast cancer in the Netherlands. J Psychosom Obstet Gynaecol. 2013;
34(4):170–8.
28. Peate M, Meiser B, Friedlander M, Zorbas H, Rovelli S, Sansom-Daly U, et al.
It’s now or never: fertility-related knowledge, decision-making preferences,
and treatment intentions in young women with breast cancer--an
Australian fertility decision aid collaborative group study. J Clin Oncol. 2011;
29(13):1670–7.
29. Peate M, Smith SK, Pye V, Hucker A, Stern C, Stafford L, et al. Assessing the
usefulness and acceptability of a low health literacy online decision aid
about reproductive choices for younger women with breast cancer: the
aLLIAnCE pilot study protocol. Pilot Feasibility Stud. 2017;3:31.
30. Corney RH, Swinglehurst AJ. Young childless women with breast cancer in the
UK: a qualitative study of their fertility-related experiences, options, and the
information given by health professionals. Psychooncology. 2014;23(1):20–6.
31. Snyder KA, Tate A. Chapter 4: Cancer-related infertility and young
women: strategies for discussing fertility preservation. In: Woodruff TK,
Clayman ML, Waimey KE, editors. Oncofertility communication–sharing
information and building relationships across disciplines. New York:
Springer; 2014. p. 49–60.
32. Garvelink MM, ter Kuile MM, Bakker RM, Geense WJ, Jenninga E, Louwe LA,
et al. Women’s experiences with information provision and deciding about
fertility preservation in the Netherlands: ‘satisfaction in general, but unmet
needs’. Health Expect. 2015;18(5):956–68.
33. Peate M, Meiser B, Hickey M, Friedlander M. The fertility-related concerns,
needs and preferences of younger women with breast cancer: a systematic
review. Breast Cancer Res Treat. 2009;116(2):215–23.
34. Couper MP, Singer E, Levin CA, Fowler FJ Jr, Fagerlin A, Zikmund-Fisher BJ. Use
of the internet and ratings of information sources for medical decisions: results
from the DECISIONS survey. Med Decis Mak. 2010;30(5 Suppl):106S–14S.
35. Hoffman AS, Volk RJ, Saarimaki A, Stirling C, Li LC, Harter M, et al. Delivering
patient decision aids on the Internet: definitions, theories, current evidence, and
emerging research areas. BMC Med Inform Decis Mak. 2013;13 Suppl 2:S13.
36. Medlock S, Eslami S, Askari M, Arts DL, Sent D, de Rooij SE, et al. Health
information-seeking behavior of seniors who use the internet: a survey. J
Med Internet Res. 2015;17(1):e10.
37. Morris D, Drake E, Saarimaki A, Bennett C, O'Connor A. Can people find patient
decision aids on the internet? Patient Educ Couns. 2008;73(3):557–60.
38. Sbaffi L, Rowley J. Trust and credibility in web-based health information: a
review and agenda for future research. J Med Internet Res. 2017;19(6):e218.
39. Legare F, Thompson-Leduc P. Twelve myths about shared decision making.
Patient Educ Couns. 2014;96(3):281–6.
40. Pollard S, Bansback N, Bryan S. Physician attitudes toward shared decision
making: a systematic review. Patient Educ Couns. 2015;98(9):1046–57.
41. Cooper C, Booth A, Britten N, Garside R. A comparison of results of
empirical studies of supplementary search techniques and
recommendations in review methodology handbooks: a methodological
review. Syst Rev. 2017;6(1):234.
42. Godin K, Stapleton J, Kirkpatrick SI, Hanning RM, Leatherdale ST. Applying
systematic review search methods to the grey literature: a case study examining
guidelines for school-based breakfast programs in Canada. Syst Rev. 2015;4(1):138.
43. Graham P, Evitts T, Thomas-MacLean R. Environmental scans: how useful are
they for primary care research? Can Fam Physician. 2008;54(7):1022–3.
44. Leiva Portocarrero ME, Garvelink MM, Becerra Perez MM, Giguere A,
Robitaille H, Wilson BJ, et al. Decision aids that support decisions about
prenatal testing for Down syndrome: an environmental scan. BMC Med
Inform Decis Mak. 2015;15:76.
45. Centre for Reviews Dissemination. Systematic Reviews: CRD's Guidance for
Undertaking Reviews in Healthcare. York: Centre for Reviews &
Dissemination; 2009. Available from: https://www.york.ac.uk/media/crd/
Systematic_Reviews.pdf . Accessed 2 Sept 2018.
46. Mahood Q, Van Eerd D, Irvin E. Searching for grey literature for systematic
reviews: challenges and benefits. Res Synth Methods. 2014;5(3):221–34.
47. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement. PLoS Med.
2009;6(7):e1000097.
48. Jones GL, Bekker H, Velikova G, Collins K, Skull J, et al. The Cancer, Fertility
and Me Patient Decision Aid: Yorkshire Cancer Research (S391); 2017.
49. Jones GL, Bekker H, Velikova G, Collins K, Skull J, et al. Cancer, Fertility and
Me: The development and evaluation of a fertility preservation decision
support intervention to support women with cancer in Yorkshire: Yorkshire
Cancer Research (S391), 1st July 2015; 2015.
50. Jones GL, Hughes J, Mahmoodi N, Greenfield D, Brauten-Smith G, Skull J, et al.
Observational study of the development and evaluation of a fertility preservation
patient decision aid for teenage and adult women diagnosed with cancer: the
Cancer, fertility and me research protocol. BMJ Open. 2017;7(3):e013219.
51. Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A
systematic development process for patient decision aids. BMC Med Inform
Decis Mak. 2013;13 Suppl 2:S2.
Mahmoodi et al. BMC Medical Informatics and Decision Making          (2018) 18:104 Page 15 of 16
52. Bekker H, Thornton JG, Airey CM, Connelly JB, Hewison J, Robinson MB, et
al. Informed decision making: an annotated bibliography and systematic
review. Health Technol Assess. 1999;3(1):1–156.
53. Bekker HL, Hewison J, Thornton JG. Understanding why decision aids work:
linking process with outcome. Patient Educ Couns. 2003;50(3):323–9.
54. Winterbottom A, Conner M, Mooney A, Bekker HL. Evaluating the quality of
patient leaflets about renal replacement therapy across UK renal units.
Nephrol Dial Transplant. 2007;22(8):2291–6.
55. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their
role in adherence to treatment in chronic physical illness. J Psychosom Res.
1999;47(6):555–67.
56. Leventhal H, Brissette I, Leventhal EA, editors. Chapter 3: the common-sense
model of self-regulation of health and illness. New York: Routledge, Taylor &
Francis Group; 2003.
57. Abhyankar P, Volk RJ, Blumenthal-Barby J, Bravo P, Buchholz A, Ozanne E, et
al. Balancing the presentation of information and options in patient
decision aids: an updated review. BMC Med Inform Decis Mak. 2013;13
Suppl 2:S6.
58. Bekker HL, Winterbottom AE, Butow P, Dillard AJ, Feldman-Stewart D,
Fowler FJ, et al. Do personal stories make patient decision aids more
effective? A critical review of theory and evidence. BMC Med Inform Decis
Mak. 2013;13 Suppl 2:S9.
59. Feldman-Stewart D, O'Brien MA, Clayman ML, Davison BJ, Jimbo M,
Labrecque M, et al. Providing information about options in patient decision
aids. BMC Med Inform Decis Mak. 2013;13 Suppl 2:S4.
60. Garvelink MM, ter Kuile MM, Stiggelbout AM, de Vries M. Values clarification
in a decision aid about fertility preservation: does it add to information
provision? BMC Med Inform Decis Mak. 2014;14:68.
61. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK,
et al. Presenting quantitative information about decision outcomes: a risk
communication primer for patient decision aid developers. BMC Med
Inform Decis Mak. 2013;13 Suppl 2:S7.
62. Bekker HL, Hewison J, Thornton JG. Applying decision analysis to facilitate
informed decision making about prenatal diagnosis for Down syndrome: a
randomised controlled trial. Prenat Diagn. 2004;24(4):265–75.
63. Abhyankar P, Bekker HL, Summers BA, Velikova G. Why values elicitation
techniques enable people to make informed decisions about cancer trial
participation. Health Expect. 2011;14(Suppl 1):20–32.
64. Fagerlin A, Pignone M, Abhyankar P, Col N, Feldman-Stewart D, Gavaruzzi T,
et al. Clarifying values: an updated review. BMC Med Inform Decis Mak.
2013;13 Suppl 2:S8.
65. Pieterse AH, de Vries M, Kunneman M, Stiggelbout AM, Feldman-Stewart D.
Theory-informed design of values clarification methods: a cognitive
psychological perspective on patient health-related decision making. Soc
Sci Med. 2013;77:156–63.
66. Witteman HO, Gavaruzzi T, Scherer LD, Pieterse AH, Fuhrel-Forbis A, Chipenda
Dansokho S, et al. Effects of design features of explicit values clarification
methods: a systematic review. Med Decis Mak. 2016;36(6):760–76.
67. McCaffery KJ, Holmes-Rovner M, Smith SK, Rovner D, Nutbeam D, Clayman
ML, et al. Addressing health literacy in patient decision aids. BMC Med
Inform Decis Mak. 2013;13 Suppl 2:S10.
68. Légaré F, Stacey D. Chapter 11: an interprofessional approach to shared
decision making: what it means and where next. In: Woodruff TK,
Clayman ML, Waimey KE, editors. Oncofertility communication–sharing
information and building relationships across disciplines. New York:
Springer; 2014. p. 131–9.
69. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al.
Developing a quality criteria framework for patient decision aids: online
international Delphi consensus process. BMJ. 2006;333(7565):417.
70. Joseph-Williams N, Newcombe R, Politi M, Durand MA, Sivell S, Stacey D, et
al. Toward minimum standards for certifying patient decision aids: a
modified Delphi consensus process. Med Decis Mak. 2014;34(6):699–710.
71. LaBrecque SF, Wallach H, Waimey KE. Oncofertility communication tools for
professionals and the public. In: Woodruff TK, Clayman ML, Waimey KE,
editors. Oncofertility communication–sharing information and building
relationships across disciplines. New York: Springer; 2014. p. 141–53.
72. Quinn GP, Vadaparampil ST, Sehovic I, Clayman ML. Chapter 3: patient and
family tools to aid in education and decision-making about oncofertility. In:
Woodruff TK, Clayman ML, Waimey KE, editors. Oncofertility
communication–sharing information and building relationships across
disciplines. New York: Springer; 2014. p. 35–48.
73. Herrmann A, Mansfield E, Hall AE, Sanson-Fisher R, Zdenkowski N. Wilfully
out of sight? A literature review on the effectiveness of cancer-related
decision aids and implementation strategies. BMC Med Inform Decis Mak.
2016;16:36.
74. Stansfield C, Dickson K, Bangpan M. Exploring issues in the conduct of
website searching and other online sources for systematic reviews: how can
we be systematic? Syst Rev. 2016;5(1):191.
75. Briscoe S. Web searching for systematic reviews: a case study of reporting
standards in the UK health technology assessment programme. BMC Res
Notes. 2015;8:153.
76. Collaboration for Environmental Evidence. Guidelines and Standards for
Evidence Synthesis in Environmental Management. Version 5.0. 2018
[Accessed 2 Sept 2018]. Available from: http://www.environmentalevidence.
org/guidelines/table-of-contents.
77. Stiggelbout AM. Chapter 11: assessing Patients’ preferences. In: Chapman
GB, Sonnenberg FA, editors. Decision making in health care: theory,
psychology, and applications. Cambridge: Cambridge University Press; 2000.
p. 289–312.
78. Selby P, Board RE, Velikova G. Chapter 1: Patient-centred and integrated
cancer care. In: Velikova A, Followfield L, Younger J, Board RE, Selby P,
editors. Problem solving in patient-centred and integrated cancer care.
Oxfordshire: EBN Health; 2018. p. 1–5.
79. Coulter A, Härter MH, Moumjid-Ferdjaoui N, Perestelo-Perez L, van der
Weijden T. European experience with shared decision making. Int J Person
Cent Med. 2015;5(1):9–14.
Mahmoodi et al. BMC Medical Informatics and Decision Making          (2018) 18:104 Page 16 of 16
